Search research articles
Contact Us
Filters
Showing results (31-40 of 180) with videos related to
Page
of 18
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 9, 1998
[Expression of DNA topoisomerases (I, II alpha, II beta) mRNA in etoposide- and mAMSA-resistant cell lines]
Y Matsumoto, H Takano, S Nagao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Do patient access schemes for high-cost cancer drugs deliver value to society?-lessons from the NHS Cancer Drugs Fund
A Aggarwal, T Fojo, C Chamberlain, et al.
Leukemia
|
July 10, 1999
Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells
M V Blagosklonny, Y Chuman, R C Bergan, et al.
Japanese Journal of Cancer Research : Gann
|
July 28, 2001
Expression of drug resistance genes in VP-16 and mAMSA-selected human carcinoma cells
Y Matsumoto, H Takano, K Kunishio, et al.
International Journal of Cancer
|
January 14, 1998
Combinations of paclitaxel and vinblastine and their effects on tubulin polymerization and cellular cytotoxicity: characterization of a synergistic schedule
P Giannakakou, L Villalba, H Li, et al.
Japanese Journal of Cancer Research : Gann
|
October 26, 2001
Incidence of mutation and deletion in topoisomerase II alpha mRNA of etoposide and mAMSA-resistant cell lines
Y Matsumoto, H Takano, K Kunishio, et al.
Japanese Journal of Cancer Research : Gann
|
July 28, 2001
Hypophosphorylation of topoisomerase IIalpha in etoposide (VP-16)-resistant human carcinoma cell lines associated with carboxy-terminal truncation
Y Matsumoto, H Takano, K Kunishio, et al.
Experimental Cell Research
|
October 15, 1998
Inhibitors of transcription, proteasome inhibitors, and DNA-damaging drugs differentially affect feedback of p53 degradation
W G An, Y Chuman, T Fojo, et al.
Oncogene
|
July 8, 2009
Impaired p53 binding to importin: a novel mechanism of cytoplasmic sequestration identified in oxaliplatin-resistant cells
E Komlodi-Pasztor, S Trostel, D Sackett, et al.
Cancer Research
|
August 28, 2001
Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228
M Kitazono, M E Goldsmith, T Aikou, et al.
Page
of 18
Search research articles
Search
Showing results (31-40 of 180) with videos related to
Sort By:
Page
of 18
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 9, 1998
[Expression of DNA topoisomerases (I, II alpha, II beta) mRNA in etoposide- and mAMSA-resistant cell lines]
Y Matsumoto, H Takano, S Nagao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Do patient access schemes for high-cost cancer drugs deliver value to society?-lessons from the NHS Cancer Drugs Fund
A Aggarwal, T Fojo, C Chamberlain, et al.
Leukemia
|
July 10, 1999
Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells
M V Blagosklonny, Y Chuman, R C Bergan, et al.
Japanese Journal of Cancer Research : Gann
|
July 28, 2001
Expression of drug resistance genes in VP-16 and mAMSA-selected human carcinoma cells
Y Matsumoto, H Takano, K Kunishio, et al.
International Journal of Cancer
|
January 14, 1998
Combinations of paclitaxel and vinblastine and their effects on tubulin polymerization and cellular cytotoxicity: characterization of a synergistic schedule
P Giannakakou, L Villalba, H Li, et al.
Japanese Journal of Cancer Research : Gann
|
October 26, 2001
Incidence of mutation and deletion in topoisomerase II alpha mRNA of etoposide and mAMSA-resistant cell lines
Y Matsumoto, H Takano, K Kunishio, et al.
Japanese Journal of Cancer Research : Gann
|
July 28, 2001
Hypophosphorylation of topoisomerase IIalpha in etoposide (VP-16)-resistant human carcinoma cell lines associated with carboxy-terminal truncation
Y Matsumoto, H Takano, K Kunishio, et al.
Experimental Cell Research
|
October 15, 1998
Inhibitors of transcription, proteasome inhibitors, and DNA-damaging drugs differentially affect feedback of p53 degradation
W G An, Y Chuman, T Fojo, et al.
Oncogene
|
July 8, 2009
Impaired p53 binding to importin: a novel mechanism of cytoplasmic sequestration identified in oxaliplatin-resistant cells
E Komlodi-Pasztor, S Trostel, D Sackett, et al.
Cancer Research
|
August 28, 2001
Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228
M Kitazono, M E Goldsmith, T Aikou, et al.
Page
of 18